COSCIENS Biopharma Inc. (CSCI) — research page
CA · ca-cm-kg/TSX/CSCI · as of 2026-11-06
Identity and listing
The issuer is COSCIENS Biopharma Inc., listed on the TSX under ticker CSCI. Its ISIN is CA22112H1010. The record holds no LEI, as the issuer has no ISIN LEI on the record. Its security type is Corporate, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). Its segment is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | COSCIENS Biopharma Inc. | source · 2026-11-06 |
| exchange | TSX | source · 2026-11-06 |
| ticker | CSCI | source · 2026-11-06 |
| ISIN | CA22112H1010 | source · 2026-11-06 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | Life Sciences | source · 2026-11-06 |
| jurisdiction | Canada (federal, CBCA) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 9 filings in the twelve months to 2026-11-06, across 9 filing days. Of these, 2 are financial statements and 7 are newswire releases. The median gap between filing days is 33.5 days. The latest filing is a newswire release dated 2026-10-19, 18 days before the record date. On the TSX, the median cadence gap is 16 days, the median filings figure is 0.0, and the median latency is 3.0 days across 2270 issuers. In the Life Sciences sector, the median cadence gap is 17.5 days, the median filings figure is 7.0, and the median latency is 14 days across 200 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 9 | 33.5 | 18 |
| exchange median: TSX (2270 issuers) | 0 | 16 | 3 |
| sector median: Life Sciences (200 issuers) | 7 | 17.5 | 14 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-19 | newswire_release | COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES | |
| 2026-09-10 | newswire_release | COSCIENS ACQUIRES NUALTIS CORP. | |
| 2026-08-11 | financial_statement | COSCIENS Biopharma Inc. Reports Q2 2026 Results | |
| 2026-07-03 | newswire_release | COSCIENS Biopharma Inc. Completes Share Capital Amendment | |
| 2026-06-23 | newswire_release | COSCIENS Biopharma Inc. Announces Details of Share Capital |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Deloitte LLP. Its location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting, name change, domicile change or segment move events. The index does not carry a type for these lifecycle lines. The issuer is listed, not halted.
Orderability
Under paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Paragraph (o) of the definition | ACM-200 |
| Paragraph (q) of the definition | ACM-200 |
rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The field has not been read. No research house coverage is recorded.
Open research
The field has not been read. No openly published research notes are recorded.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.tsx.com/json/company-directory/search/tsx/^* (identity.exchange)
- 10.2
- https://stockanalysis.com/quote/tsx/CSCI/company (identity.isin)
- 10.3
- https://www.stocktitan.net/sec-filings/CSCI/20-f-cosciens-biopharma-inc-files-annual-report-foreign-issuer-d894827f0f8f.html (identity.jurisdiction)
- 10.4
- https://www.tsx.com/en/resource/571 (identity.sector)
- 10.5
- https://mcp.ca-cm-kg.ai/events/TSX/CSCI (the disclosure lines)
- 10.6
- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
- 10.7
- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.ca-cm-kg.ai/record/TSX/CSCI (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"CA22112H1010"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f8e6ab6d05fda95a.